UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004509
Receipt number R000005387
Scientific Title Clinical trial of sitafloxacin against non-gonococcal urethritis
Date of disclosure of the study information 2010/11/05
Last modified on 2013/11/06 10:00:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial of sitafloxacin against non-gonococcal urethritis

Acronym

Clinical trial of STFX against NGU

Scientific Title

Clinical trial of sitafloxacin against non-gonococcal urethritis

Scientific Title:Acronym

Clinical trial of STFX against NGU

Region

Japan


Condition

Condition

Non-gonococcal urethritis

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The efficacy of STFX 200mg/day for 7days is examined against non-gonococcal
urethritis

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Microbiological efficacy of STFX against causative bacteria(mMycoplasma genitalium,Chlamydaia trachomatis,Ureaplasma urealyticum)is investigated in non-gonococcal urethritis.

Key secondary outcomes

Clinical efficacy of STFX is investigated in non-gonococcal urethritis.
Validation of new nucleic acid amplification testing for detecting M.genitalium or U.urealyticum is validated.
Antimicrobial susceptibility of M.genitalium or U.urealyticum
Analysis of genome ralated to resistance to antimicrobials in M.genitalium


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

STFX 200mg/day 7days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male

Key inclusion criteria

Outpatients with non-gonococcal urethritis between 20 and 65 years old.
Patients who undersutand the study and agree with written informed consent.
Ptients agree that they do not have sexual intercourse without using condom during the period of clinical trial.

Key exclusion criteria

Patients who have allegy to fluoroquinolones
Patients with severe renal dysfunction
Patients who have a history of epilepsy.
Patients who have severe heart diseases including inchemic heart diseases or arrthythmia.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Takahashi

Organization

Sapporo Medical university School of Medicine

Division name

Department of Urology

Zip code


Address

W.16 Chuo-ku, Sapporo, 060-8542,japan

TEL

(011)611-2111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Satoshi Takahashi

Organization

Sapporo Medical university School of Medicine

Division name

Department of Urology

Zip code


Address

W.16 Chuo-ku, Sapporo, 060-8542,japan

TEL

(011)611-2111

Homepage URL


Email



Sponsor or person

Institute

NPO CREC net

Institute

Department

Personal name



Funding Source

Organization

Daiichisankyo

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

札幌医科大学附属病院泌尿器科(北海道)
ていね泌尿器科(北海道)
にっしん泌尿器科(北海道)
岐阜大学医学部附属病院(岐阜)
あいクリニック(宮城)
竹内クリニック(岐阜)
ふくだ泌尿器科(宮崎)
医療法人泌尿器科いとうクリニック(福岡)
医療法人かわい泌尿器科クリニック(福岡)
医療法人西村泌尿器科(福岡)
医療法人山口皮フ・泌尿器科(福岡)


Other administrative information

Date of disclosure of the study information

2010 Year 11 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 09 Month 06 Day

Date of IRB


Anticipated trial start date

2010 Year 11 Month 01 Day

Last follow-up date

2011 Year 12 Month 01 Day

Date of closure to data entry

2012 Year 04 Month 01 Day

Date trial data considered complete

2012 Year 04 Month 01 Day

Date analysis concluded

2012 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 11 Month 05 Day

Last modified on

2013 Year 11 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005387